The importance of access to highly effective direct acting antiviral (DAA) treatments to help eliminate hepatitis C (HCV) among people living with HIV (PLHIV) has been demonstrated in new research led by Burnet Institute, published in the journal eClinicalMedicine.
from Medical Xpress - latest medical and health news stories https://ift.tt/ptEhXOd
